Total Payments
$8,000
2024 Payments
$794.19
Companies
43
Transactions
367
Medicare Patients
2,393
Medicare Billing
$233,188
Payment Breakdown by Category
Food & Beverage$7,910 (98.9%)
Education$90.00 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,910 | 365 | 98.9% |
| Education | $90.00 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $983.32 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $958.80 | 46 | $0 (2024) |
| Novo Nordisk Inc | $792.81 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $686.27 | 15 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $624.08 | 34 | $0 (2022) |
| Lilly USA, LLC | $364.55 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $354.10 | 10 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $349.15 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $317.51 | 12 | $0 (2019) |
| Merck Sharp & Dohme LLC | $306.11 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $794.19 | 35 | GlaxoSmithKline, LLC. ($181.97) |
| 2023 | $581.30 | 25 | GlaxoSmithKline, LLC. ($161.73) |
| 2022 | $679.20 | 37 | GlaxoSmithKline, LLC. ($190.86) |
| 2021 | $1,090 | 64 | GlaxoSmithKline, LLC. ($229.37) |
| 2020 | $630.58 | 31 | E.R. Squibb & Sons, L.L.C. ($134.23) |
| 2019 | $939.68 | 42 | Boehringer Ingelheim Pharmaceuticals, Inc. ($150.25) |
| 2018 | $1,581 | 58 | SANOFI-AVENTIS U.S. LLC ($309.70) |
| 2017 | $1,705 | 75 | SANOFI-AVENTIS U.S. LLC ($329.50) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.09 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Obesity | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: VACCINE | ||||||
| 08/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: ANTIBIOTIC | ||||||
| 08/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.02 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Obesity | ||||||
| 05/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.28 | General |
| Category: PSYCHIATRY | ||||||
| 04/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 04/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 493 | 791 | $128,136 | $44,914 |
| 2022 | 16 | 583 | 1,082 | $170,605 | $60,493 |
| 2021 | 17 | 612 | 1,017 | $155,504 | $60,927 |
| 2020 | 19 | 705 | 1,187 | $165,005 | $66,854 |
Total Patients
2,393
Total Services
4,077
Medicare Billing
$233,188
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 89 | 249 | $43,575 | $15,053 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $18,550 | $6,622 | 35.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 40 | 50 | $13,750 | $6,441 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 70 | $15,750 | $5,656 | 35.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 43 | 45 | $10,125 | $4,483 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 43 | $6,880 | $1,813 | 26.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 14 | 17 | $2,380 | $917.44 | 38.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 16 | $1,600 | $644.16 | 40.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 17 | 19 | $1,330 | $581.21 | 43.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 22 | $2,310 | $555.99 | 24.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 23 | 40 | $4,000 | $524.80 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 31 | 54 | $675.00 | $438.48 | 65.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 24 | 40 | $2,860 | $414.00 | 14.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 13 | 21 | $1,622 | $345.66 | 21.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 24 | 40 | $2,000 | $304.40 | 15.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $729.00 | $119.72 | 16.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 82 | 401 | $70,175 | $24,387 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $21,000 | $8,083 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 93 | $20,925 | $7,106 | 34.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 46 | 51 | $14,025 | $6,421 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 47 | $7,520 | $2,908 | 38.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $6,175 | $2,726 | 44.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 34 | 42 | $5,880 | $1,751 | 29.8% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2022 | 23 | 23 | $4,025 | $1,697 | 42.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $1,650 | $1,505 | 91.2% |
About Dr. Arun Patel, MD
Dr. Arun Patel, MD is a Geriatric Medicine healthcare provider based in Salamanca, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205815255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arun Patel, MD has received a total of $8,000 in payments from pharmaceutical and medical device companies, with $794.19 received in 2024. These payments were reported across 367 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,910).
As a Medicare-enrolled provider, Patel has provided services to 2,393 Medicare beneficiaries, totaling 4,077 services with total Medicare billing of $233,188. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Salamanca, NY
- Active Since 01/10/2006
- Last Updated 04/08/2025
- Taxonomy Code 207QG0300X
- Entity Type Individual
- NPI Number 1205815255
Products in Payments
- TRELEGY ELLIPTA (Drug) $498.79
- XARELTO (Drug) $476.09
- ELIQUIS (Drug) $377.23
- TOUJEO (Drug) $360.81
- ENTRESTO (Drug) $317.51
- FARXIGA (Drug) $306.40
- Ozempic (Drug) $278.97
- SOLIQUA (Drug) $267.14
- AREXVY (Drug) $249.90
- REXULTI (Drug) $224.09
- Prolia (Biological) $196.80
- Victoza (Drug) $193.72
- BYDUREON (Drug) $178.82
- JANUVIA (Drug) $173.72
- BEVESPI AEROSPHERE (Drug) $169.18
- LOKELMA (Drug) $148.79
- INVOKANA (Drug) $147.99
- JARDIANCE (Drug) $146.63
- NUPLAZID (Drug) $136.55
- UTIBRON (Drug) $135.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.